COMMUNIQUÉ DE PRESSE publié le 01/10/2024 à 06:55, il y a 1 année 11 mois Leclanché SA: Announces Extension of Publication Deadline for 2024 Interim Results Due to Ongoing Due Diligence with Pinnacle International Capital Leclanché extends publication deadline for 2024 interim results due to ongoing due diligence with Pinnacle International Capital, approved by SIX Exchange Regulation AG Due Diligence Leclanché Publication Deadline Pinnacle International Capital 2024 Interim Results
COMMUNIQUÉ DE PRESSE publié le 01/10/2024 à 06:50, il y a 1 année 11 mois Daldrup & Söhne AG doubles EBIT in H1 2024 Daldrup & Söhne AG doubles EBIT in H1 2024, achieving group total revenues increase and confirming raised forecast for 2024 Revenues EBIT Forecast Geothermal Energy Daldrup & Söhne AG
COMMUNIQUÉ DE PRESSE publié le 01/10/2024 à 06:20, il y a 1 année 11 mois SFS acquires leading Slovenian distribution partner in the construction industry SFS Group acquires EPRO D.O.O., a leading Slovenian distribution partner in the construction industry, strengthening its presence in the Adriatic region markets Acquisition Construction Industry Slovenia SFS Group EPRO D.O.O.
COMMUNIQUÉ DE PRESSE publié le 01/10/2024 à 02:05, il y a 1 année 11 mois High Grade Tarcoola Assays Confirm Additional Open Pit Gold Barton Gold confirms new high-grade open pit floor assays at Tarcoola Gold Project, supporting potential JORC Resource extensions. MD Scanlon anticipates additional gold ounces for 'Stage 1' operation Barton Gold Tarcoola Gold Project High-grade Assays JORC Resources Stage 1 Operation
COMMUNIQUÉ DE PRESSE publié le 01/10/2024 à 02:00, il y a 1 année 11 mois Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines Moderna Inc. and Cenra Healthcare enter joint agreement to co-promote mRNA respiratory vaccine portfolio in Taiwan, enhancing public health initiatives. Details undisclosed Moderna Taïwan MRNA Vaccine Cenra Healthcare Joint Agreement
COMMUNIQUÉ DE PRESSE publié le 01/10/2024 à 00:51, il y a 1 année 11 mois Inside Information: News release on accounts, results Valerio Therapeutics annonce ses résultats financiers du Premier Semestre 2024 et fait le point sur ses activités, y compris l'acquisition d'Emglev Therapeutics et le développement de la plateforme PlatONTM Résultats Financiers Biotechnologie Valerio Therapeutics Emglev Therapeutics Plateforme PlatONTM
COMMUNIQUÉ DE PRESSE publié le 01/10/2024 à 00:40, il y a 1 année 11 mois Inside Information: News release on accounts, results Valerio Therapeutics reports its half-year 2024 financial results and updates on its activities, including the acquisition of Emglev Therapeutics and progress on the VIO-01 trial Acquisition Financial Results Valerio Therapeutics VIO-01 Trial Emglev Therapeutics
COMMUNIQUÉ DE PRESSE publié le 30/09/2024 à 23:00, il y a 1 année 11 mois Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities Biophytis publishes first-half financial results and business activities update, including launch of obesity program and licensing agreement with Blanver for Latin America, with a focus on key achievements and financial highlights Financial Results Biophytis Licensing Agreement Business Activities Obesity Program
COMMUNIQUÉ DE PRESSE publié le 30/09/2024 à 23:00, il y a 1 année 11 mois Biophytis publie ses comptes semestriels et fait le point sur ses activités Biophytis publie ses comptes semestriels et fait le point sur ses activités. La société présente ses résultats financiers pour le premier semestre 2024 et annonce les prochaines étapes de développement de ses programmes cliniques Biophytis Partenariat BIO101 Obésité Comptes Semestriels
COMMUNIQUÉ RÉGLEMENTÉ publié le 30/09/2024 à 23:00, il y a 1 année 11 mois Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities Biophytis publishes first-half financial results and updates on business activities, highlighting key achievements including launch of OBA program for obesity with BIO101 and exclusive licensing agreement with Blanver for Latin America Financial Results Biophytis Latin America BIO101 OBA Program
Publié le 11/09/2026 à 07:00, il y a 1 jour 8 heures BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Publié le 11/09/2026 à 07:00, il y a 1 jour 8 heures BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Publié le 10/09/2026 à 19:30, il y a 1 jour 19 heures Availability of the 2026 Interim Financial Report
Publié le 12/09/2026 à 02:35, il y a 12 heures 51 minutes Gamma Resources Announces Extension of Private Placement Closing Date
Publié le 11/09/2026 à 23:00, il y a 16 heures 26 minutes Rio Grande Resources Engages Machai Capital for Investor Outreach
Publié le 11/09/2026 à 22:05, il y a 17 heures 21 minutes Usha Resources Announces Leadership Transition
Publié le 11/09/2026 à 21:25, il y a 18 heures 1 minute Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Publié le 11/09/2026 à 17:00, il y a 22 heures 26 minutes Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Publié le 12/09/2026 à 07:30, il y a 7 heures 56 minutes NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Publié le 11/09/2026 à 22:15, il y a 17 heures 11 minutes Amrize Appoints Mario Gross as President of Building Envelope
Publié le 11/09/2026 à 22:10, il y a 17 heures 16 minutes Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Publié le 11/09/2026 à 19:44, il y a 19 heures 41 minutes DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Publié le 11/09/2026 à 18:15, il y a 21 heures 11 minutes CGTN: How BRICS creates new opportunities for Global South development